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CHAPTER-I 
1. INTRODUCTION 
1.1. Peptic ulcer 
Peptic ulcer and other acidic symptom affect up to ten percentages of the 
humans with sufficient severity to prompt victims to seek medical attention. 
The more significant disease condition requiring medical focus is ulcer and 
gastro esophagealdisease1.In the US, approximately 4 million people have 
peptic ulcer (duodenal and gastric types), and 350 thousand new patient are 
diagnosed in each year, around 180 thousand peoples are admitted to 
hospital and treated with drugs yearly, and about five thousand patient from 
this case die each year as a result of ulcer condition. The lifetime of human 
being developing a peptic ulcer is about 10 percentages for Americans males 
and four percentages for female population2. 
Peptic ulcers is  wound in the lesions in the stomach and GIT that are most 
often affected in younger to older adults population, but this may  diagnosed 
in young adult life. They often appear without obvious sign and symptom, after 
a period of days to months of active phase of disease, it may heal with or 
without drug treatment. It also affect because of bacterial infections with H. 
Pylori.  
Fig. No: 1: Diagram of Peptic Ulcer 3 
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The following statistics relate to the prevalence of peptic ulcer4: 
Table.  No: 1: Prelavance of peptic ulcer 
Country/Region   Extrapolated 
prevalence 
Population estimated 
used 
USA                      5,398,077 293,655,405 
Canada  597,571  32,507,874 
India  19,578,503  1,065,070,607 
Russia   2,646,581 143,974,059 
Australia   366,050 19,913,144 
 
 1.2. Risk factor for ulcer5  
1.2.1. Bleeding 
 Upper gastrointestinal (UGI) bleeding is the secondary common medical 
condition that effect high mortality in peptic ulcer. UGI bleeding commonly 
present along with hematemesis (vomiting with digested food and blood or 
coffee-ground like substance) and black, tarry stools (melana). Clinical 
diagnosis of UGI done by nasogastric tube lavage shows blood or coffee-
ground like material presence. However this diagnosis may be negative when 
the bleeding arises beyond a closed pylorus region. Most of the patient’s 
having bleeding ulcers can be treated with fluid and blood resuscitation, drug 
therapy, and endoscopic surgery.  
1.2.2. Perforation: this ulcer may be spread to small intestine, oesophagus 
and large intestine ulcers account for 60, 20 and 20 percentage of 
perforations.  
1.2.3. Penetration 
 Ulcer penetration called due to the permeation of the ulcer among the bowel 
part without free perforation and filtration of whole contents inside the 
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peritoneal cavity. Surgical treatment regimen recommended that permeation 
affect in twenty percentage of ulcers, but little proportion of penetrating ulcers 
become clinically important. The common symptom these complications 
include acidic irritation, weight reduction and diarrhoea: watery vomiting is an 
uncommon, but diagnostic symptom.  No evident clinical data is available in 
the treatment regimen and guidance for the curing of penetrating ulcers.  
1.2.4. Obstruction 
 Gastric wall obstruction among the frequent ulcer symptoms. Most of the 
cases are related with duodenal or pyloric part ulceration are 5 percentage of 
the patient populations. 
1.2.5. Changes in lifestyle and dietary 
Aspirin and related drugs (non-steroidal anti-inflammatory drugs), alcohol, 
coffee (even caffeine) and tea can interfere with the curing of the peptic 
ulcers. 6,7,8,9&10 Smoking may also low the ulcer healing process11. People with 
ulcer symptom have been evaluated to have more carbohydrate than people 
with no ulcers12 from this route may occur with a genetic susceptibility for the 
ulcer pathogenis13. 
Sugar has also been reported to increase stomach pH14. Salt may cause the 
stomach and intestine irritation. Large uptakes of salt have been linked to 
higher risk of stomach ulcer15 
One of the amino acid Known as Glutamine, is the important source in the 
energy in cells which cover the stomach and intestine16. It is also prevent the 
stress ulcer related by large burns of the preliminary study about the 
pathogenesis of ulcers17. 
1.3. Types of Peptic Ulcer     
1) Gastric ulcer  
2) Duodenal ulcer 
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1.3.1. Gastric ulcer2 
Gastric ulcers are usually single and less than 20 millimetres in diameters. 
Ulcers on the small curvature are mainly related for the chronic gastritis 
condition, whereas those in the larger curvature are often associated to the 
non-steroidal anti-inflammatory drugs effects. 
Gastric ulcers almost invariably arise in the setting of H. pylori gastritis or 
chemical gastritis that results in injury to epithelium. Most patients with gastric 
ulcers secrete less acid than do those with duodenal ulcers and even less 
than normal persons. The factors implicated include:  
(1) back-diffusion of acid into the mucosa,  
(2) Decreased parietal cell mass,  
 (3) Abnormalities of the parietal cells themselves.  
A minority of patients with gastric ulcers exhibit acid hyper secretion. In 
these persons, the ulcers are usually near the pylorus and are considered 
variants of duodenal ulcers. Interestingly, the intense gastric hyper secretion 
that occurs in the Zollinger-Ellisonsyndrome is associated with severe 
ulceration of the duodenum and even the jejunum but rarely with gastric 
ulcers. 
1.3.2. Duodenal ulcer  
Duodenal ulcers are ordinarily located on the walls of the duodenum, on a 
short distance of the pylorus region.  
The maximal capacity for acid production by the stomach reflects total parietal 
cell mass. Both parietal cell mass and maximal acid secretion are increased 
up to twofold in patients with duodenal ulcers. However, there is a large 
overlap with normal values and only one third of these patients secrete 
excess acid.  
Accelerated gastric emptying, a condition that might lead to excessive 
acidification of the duodenum, has been noted in patients with duodenal 
ulcers. However, as with other factors, there is substantial overlap with normal 
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rates. Normally, acidification of the duodenal bulb inhibits further gastric 
emptying. 
The pH of the duodenal bulb reflects the balance between the delivery of 
gastric juice and its neutralization by biliary, pancreatic and duodenal 
secretions. The production of duodenal ulcers requires an acidic pH in the 
bulb, that is, an excess of acid over neutralizing secretions. In ulcer patients, 
the duodenal pH after meal decreases to a lower level and remains 
depressed for a longer time than that in normal persons. 
Impaired mucosal defences have been invoked as contributing to peptic 
ulceration. The mucosal factors, including the function of prostaglandins, may 
or may not be similar to those protecting the gastric mucosa. 
Table NO: 2:Distinguishing features of two major forms of peptic ulcer23: 
  Features                       Duodenal ulcer                               Gastric ulcer 
 
1. Incidence       
a. Four times more common 
than gastric ulcers and     
b. Usual age 25-50 years. 
Less common than duodenal 
ulcers and Usually beyond 
6th decade. 
 
 
2.  Etiology 
 
 
Most commonly as a result 
of H. pylori infection and 
other factors-hyper 
secretion of acid-pepsin, 
association with alcoholic 
cirrhosis, tobacco, 
hyperparathyroidism, 
chronic   pancreatitis, blood 
group O, genetic factors.          
Gastric colonisation H. pylori 
asymptomatic but higher 
chances of development of 
duodenal ulcer. Disruption of 
mucus barrier most important 
factor. Association with 
gastritis, bile reflux, drugs, 
alcohol, tobacco. 
 
3. 
Pathogenesis    
 
Mucosal digestion from 
hyperacidity most significant 
factor. 
Protective mucus barrier 
may be damaged. 
Usually normal to low acid 
levels  
Damage to mucus barrier 
significant factor. 
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4.Pathologic       
changes 
(a). Most common in the 
first part of duodenum.  
(b).1-2.5 cm in size. Round 
to oval. 
(a) Most common along the 
lesser curvature and pyloric 
antrum.  
(b) Same to duodenal ulcer. 
 
 
5.Clinical     
features 
 
Pain-food-relief pattern 
Night pain common 
No vomiting 
No loss of weight 
No particular choice of diet  
Marked seasonal variation 
Occur more in people at 
greater stress. 
Food-pain pattern 
No night pain 
Vomiting common   
loss of weight 
Patients choose bland diet 
devoid of curries 
No seasonal variation 
More often in labouring 
groups 
 
1.4.Anatomy of Stomach 
1.4.1.Parts of the stomach 
The stomach is divided into five parts: a cardiac part, fundus, body, pyloric 
part and pylorus25. 
1.4.2. Cardiac 
 This part situated in the left side of the midline behind cardiac orifice region. 
1.4.3. Fundus 
 This is a rounded part of the stomach receive the initial food and it controlled 
by splinter muscle. 
1.4.4. Body 
 This is the main part of the stomach, it situated between the fundus and 
pyloric region. 
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1.4.5. Pyloric Part: 
This contain a wide part, the pyloric region and a narrow pyloric tube.  
1.4.6. Pylorus 
 the pylorus wall is thicker part because made up of extra circular smooth 
muscle.  
 
 
 
 
Fig. No: 2 : Layers of stomach26 
 
1. Serosa 
2. Connective tissue layer 
3. Visceral peritoneum 
4. Muscularis 
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5. Oblique muscle layer 
6. Circular muscle layer 
7. Longitudinal muscle layer 
8. Submucosa 
9. Muscularis 
10. Gastric surface 
11. Epithelium 
12. Gastric glands 
13. Gastric pits 
14. Mucosa 
The stomach walls are made up of the 4 basic layers which present in the 
entire GIT, with little modified anatomy. The surface about mucosa as the 
layers of simple columnar epithelial cells. 
Epithelial cells extends down to the columns of secreting cells are known 
as gastric pits. Secretions from many gastric glands accumulated inside the 
gastric pit extended through inside the stomach. The gastric glands contain 
three types of exocrine secreting cells that release their secreting products 
inside the stomach it responsible for the absorption of vitamin B12, and 
hydrochloric acid27. The normal adult may produce gastric juice 2000-3000ml 
per day 
 1.5. Physiology of Stomach24 
Stomach is a hollow organ situated just below the diaphragm on the left 
side in the abdominal cavity. When empty, its volume is 50ml and normally it 
can expand to accommodate 1 to 1.5 litters of solids and liquids. Gastric juice 
is the mixture of secretions from different glands of the stomach. 
1.6. Properties 
 Its volume ranges from 1200 to 1500 ml/day. Gastric juice is highly acidic 
with pH of 0.9 to 1.2. The acidity of gastric juice is due the HCl. The specific 
gravity ranges from 1.002 to 1.004. 
       Page 9 
 
1.7. Composition 
 It contains 99.5% of water and 0.5% solids. The solids are organic and 
inorganic substances.  
1.8. Organic substances  
1.8.1. Gastric enzymes 
 The enzymes present in gastric juice are pepsin, rennin, lipase and other 
enzymes. 
1.8.2. Pepsin 
 This is the major protein splitting enzyme in the gastric juice. the precursor of 
pepsin is pepsinogen. 
1.8.3. Rennin 
 It is a milk curdling enzyme.  
1.8.4. Gastric lipase 
 It is a weak lipid splitting enzyme. 
1.8.5. Other gastric juice 
 The other enzymes of gastric juice are the gelatinase and urase. 
1.8.6. Gastric mucus 
 It is secreted by mucus neck cells of the gastric glands and surface mucus 
cells in fundus, body and others parts of stomach. It is like a flexible gel 
covering the gastric mucus membrane. Mucus is a glycoprotein. 
1.8.7. Intrinsic Factor 
 This is necessary for absorption of the extrinsic factor. 
 1.8.8. Inorganic substances  
The Inorganic substances present in the gastric juice are HCL, sodium, 
calcium, potassium, chloride, bicarbonate, phosphate and sulfate. 
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1.9. Process of Digestion28 
1.9.1. Mechanical digestion 
After the ingestion food it enters stomach through oesophagus it 
undergoes peristaltic movements called mixing waves happened in every 25 
to 30 seconds. These helped the maceration of food particle, mixing it with 
gastric fluid to form a semisolid consistency is called chyme.   
These intense and more vigorous mixing waves promoted to reach the 
pylorus.  Pyloric sphincter normally not fully closed it is partially closed. The 
chyme reaches the pylorus, these wave forces many millilitres of chyme into 
the small intestine by the pyloric sphincter. Sometime the chyme is forced 
return back into the stomach body parts, the mixing process continued. These 
forward and backward transport of the chyme are the responsible for most 
mixing process inside the gastro intestinal tract. 
Foods may accumulate in the fundus for up to an hour without that 
mixed with gastric secretion. During this process, digestion process through 
salivary amylase continues inside the stomach.  
1.9.2. Chemical Digestion 
The partial cells produce the hydrogen ions (H+) and chloride ions (Cl-) 
separately inside the stomach lumen; the total effect is secretion of 
hydrochloric acid (HCl). Proton pumps powered by H+ / K+ ATPase energy 
used to transport H+ inside the stomach which transport the potassium ions 
(K+) into the cells. The enzyme carbonic anhydrase, which is responsible for 
the parietal cells, which catalyses the synthesis of carbonic acid from water 
and carbon dioxide 
The strongly acidic nature of the stomach digest many microbes in food 
and HCl partially digest the proteins inside the food and responsible the 
secretion of hormones interrelated to promote the secretion of bile in gall 
bladder and pancreatic juice from pancreases. Enzymatic digestion of 
proteins started in side stomach lumen. The proteolytic enzyme secreted 
inside the stomach is known as pepsin, function of these enzyme is the 
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breakdown of selective peptide bonds between the amino acids making up 
proteins. Pepsin is most active in acidic environment of the stomach (pH 2): it 
is inactive in higher pH. Other enzyme inside the stomach is gastric lipase, 
which break the short chain triglycerides. This enzyme have a little function 
inside the adult stomach, it active at pH range of 5-6 
Only a little concentration of absorption happened through stomach, 
because epithelial cell of the stomach is impermeable of the chemical 
substances but  it absorbed some amount of water or aqueous vehicle, ions,  
certain therapeutic agents. 
 
1.10. Phases of gastric secretion29,30: 
Secretion of gastric juice occurs when the food is taken in the mouth. 
Neural and hormonal mechanisms are involved in gastric secretion, which 
occurs in three phases: 
Cephalic phases 
Gastric phases 
Intestinal phases 
1.10.1. Cephalic phases 
 This is solely under nervous control. While taking food, the secretion of 
gastric juice starts even before food enters the stomach. The impulses are 
sent from head and so this phase is called cephalic phase. The gastric juice 
secreted in this phase is called appetite juice. This occur as conditioned and 
unconditioned reflex. In both, pepsinogen and HCL are secreted. 
1.10.2. Unconditioned reflex 
 This causes gastric secretion when food is placed in the mouth. Afferent 
impulses arise from taste buds and other receptors in the mouth and reach 
the appetite center in amygdala and hypothalamus. From here, the efferent 
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impulses pass through dorsal nucleus of vagus and vagal fibers to the wall of 
the stomach. The gastric secretion occurs by the release of acetylcholine. 
1.10.3. Conditioned reflex 
In this, the sight, smell, hearing or thought of food causes gastric secretion. 
The impulses arising from cerebral cortex reach stomach via vagus.  
1.10.4. Gastric phases 
 This is under both nervous and hormonal   control. When food enters the 
stomach, secretion of gastric juice increases which is rich in pepsinogen and 
HCL mechanisms involved in this phase of gastric secretion are:  
 1.10.4.1. Local mesenteric reflex 
When food enters the stomach, the food particles stimulate the local nerve 
plexus in the wall of the stomach. These nerves, in turn activate the glands of 
the stomach and a large quantity of gastric juice is secreted.  
1.10.4.2. Vagovagal reflex 
Presence of food in stomach stimulates the sensory nerve endings. Now the 
sensory impulses pass to the brainstem via sensory fibers of vagus. The 
efferent impulses pass through the motor fibers of vagus back to stomach and 
cause secretion. 
1.10.4.3. Gastrin mechanism 
Gastrin is one of the gastrointestinal hormones. It is secreted by the G 
cells present in pyloric glands of stomach. Small amount is also secreted in 
mucosa of upper small intestine. In foetus, it is also secreted by islets of 
Langerhans in pancreas. Gastrin is a polypeptide containing G14, G17 or G34 
amino acids. 
The intestinal phase of gastric digestion is due to activation of receptors in the 
small intestine. Whereas reflexes started from the cephalic and gastric phases 
initiate the stomach secret ration and gastric motility, these happened during 
the intestinal phase will be reduce the chime overloading in duodenum. In 
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addition, response happened during the intestinal phase helped the 
continuous digestion of foods that passed in the small intestine. The chyme 
having fatty acids and glucose absorbed the stomach and enter in to the small 
intestine, it triggers enteroendocrine cells in the small intestinal mucosa to 
release into the blood two hormones that affect the stomach-secretin and 
cholecystokinin or CCK. With respect to the stomach, secretin mainly 
decreases gastric secretion, whereas CCK mainly inhibits stomach emptying. 
Both hormones have other important effects on the pancreas, liver and 
gallbladder that contribute to the regulation of digestive processes 
1.11. Causes of Peptic Ulcer 
1.11.1. Helicobacter pylori (H. pylori) 
 Helicobacter pylori is a type (spiral shaped) Gram-negative bacterium that 
grown in the stomach is about fifty percentage of human population. 
Helicobacter pylori is freely adapted for survival inside environment of 
stomach. It attaches to the surface epithelial cells of the mucus, have higher 
urease action produces ammonia which balance the neutral 
microenvironment for its survival. It is now identified as an important aetiology 
for the chronic gastritis, and peptic ulcer. The Helicobacter pylori is always 
responsible for inflammation inside the gastric mucosa identified by 
inflammatory cells. The Helicobacter pylori infection responsible for higher 
amount acid secretion from the gastric pits of the stomach. Once identified the 
H. pylori generally exists for the up to 90 percentage of people having 
duodenal and gastric ulcer conformed31. 
1.11. 2. Non-steroidal anti-inflammatory drugs (NSAIDs) 
 Ongoing use of this class of medications is the second most common cause 
of ulcers. These drugs (which include aspirin, ibuprofen, naproxen, diclofenac, 
tolmetin, piroxicam, fenoprofen, indomethacin, oxaprozin, ketoprofen, 
sulindac, nabumetone, etodolac and salicylates) are acidic and they block 
prostaglandins, substances in the stomach that help maintain blood flow and 
protect the area from injury. Some of the specific drugs listed are more likely 
to produce ulcers than others32. 
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1.11. 3. Zollinger–ellison syndrome 
  The Zollinger-Ellison (ZE) syndrome is characterized by autonomous gastrin 
production by an adenoma or adenocarcinoma of the pancreas or duodenum. 
The Zollinger-Ellison syndrome is distinguished from peptic ulcer disease by 
the demonstration of fasting hyper gastrinemia. There are many causes of 
fasting hyper gastrinemia (gastritis, vagotomy and pyloroplasty, the short 
bowel syndrome, rheumatoid arthritis, retained antrum, G-cell hyperplasia), 
but only two conditions-atrophic gastritis and renal failure are associated with 
gastrin levels increased several times above the upper limit of the normal 
range. However, in a patient with peptic ulcer disease and hypergastrinemia, 
it is important to exclude the Zollinger-Ellison syndrome. The Zollinger-Ellison 
syndrome arises from a gastrinoma, a tumour in the pancreas. This may be a 
localized or diffuse tumor. The presence of hypergastrinemia leads to hyper 
secretion; while the maximal acid output may be increased, the major defect 
is basal hypergastrinemia and a marked increase in the basal acid output. 
The patient will have aggressive peptic ulcer disease with ulceration in 
unusual sites or multiple ulcers that fail to heal on medical therapy. 
Hypertrophic gastric folds and diarrhoea may be prominent features33. 
1.11.4. Hereditary factors 
 Hereditary factors are important in the pathogenesis of peptic ulcer disease, 
as suggested by a higher prevalence of peptic ulcer disease in certain genetic 
syndromes. A number of familial aggregations have been noted in patients 
with peptic ulcer disease. These include hyperpepsinogenemia 1, normal 
pepsinogenemia 1, antral G-cell hyper function, rapid gastric emptying, 
childhood duodenal ulcer and immunologic forms of peptic ulcer disease. 
Heredity also plays a role in the development of ulceration and is associated 
with the syndrome of multiple endocrine adenomatosis 1 (adenomas of the 
pancreas, pituitary and parathyroid). Parents, siblings and children of ulcer 
patients are more likely to have peptic ulcer disease than control individuals. 
There is greater concordance for ulcer disease in identical than in fraternal 
twins. Hyperpepsinogenemia 1 appears to be an autosomal dominant trait. 
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There is increasing evidence to suggest that familial peptic ulcer disease is 
related to Helicobacter pyloric infection amongst family members34. 
1.11. 5. Male sex 
 Among the male and female ratio for gastric ulcers up to 1.5:2.1 percentage 
and duodenal ulcers about three: one35. 
1.11. 6.Cigarette smoking 
 Smoking is associated with a higher prevalence of peptic ulcer disease and 
may be associated with impaired healing of duodenal and gastric ulcer 
disease. Also, death rates from peptic ulcer disease are higher in individuals 
who smoke. Smoking increases a person's risk of getting an ulcer because 
the nicotine in cigarettes causes the stomach to produce more acid.  
1.11. 7. Pepsinogen-1 
 It is secreted by the chief and mucous neck cells of the gastric mucosa and 
appears in the gastric juice and urine. Serum levels of this proenzyme 
correlates the gastric capacity for acid secretion and are considered a 
measure of parietal cell mass. A person with a high level of pepsinogen-1 is at 
five times the normal of developing a duodenal ulcer. Hyperpepsinogenemia 
is present in half of children of ulcer patients with hyperpepsinogenemia37. 
1.11. 8. Alcoholic cirrhosis 
 Ulcers are more common in people who have cirrhosis of the liver. Since 
cirrhosis of the liver is associated with alcohol consumption, alcohol reduction 
may work as a preventive measure to reduce the risk of peptic ulcer. Also 
alcohol is thought to slow wound healing increasing the risk of bleeding 
ulcers. Consumption of alcohol significantly increases the risk of gastric 
ulcers38. The cyclo-oxygenase-2 (COX-2) inhibitors exert their therapeutic 
effect by blockage of the synthesis of prostaglandins which mediate the 
inflammation. At therapeutic dose regimen doses they are very little or no 
secretary effect on cyclo-oxygenase-1, which found in various tissues which is 
responsible for the production of the prostaglandins which prevent the upper 
gastrointestinal tract ulceration.  The COX-2 inhibitors will be decrease gastro 
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duodenal toxicity comparing to the conventional NSAIDs treatment regimen. 
The COX-2 inhibitors, like NSAIDs, may also aggravate the inflammatory 
bowel symptoms and leading to intestinal strictures39. 
1.11.9. COPD 
 Gastrointestinal symptoms could be related to the high incidence of peptic 
ulcer disease in patients with Chronic obstructive pulmonary diseases 
(COPD), to abdominal discomfort caused by bronchodilator drugs or 
corticosteroids, or to early satiety caused by flattened diaphragm or air 
swallowing40.Glucocorticoids increase the secretion of hydrochloric acid, 
pepsinogen and pancreatic trypsinogen. They increase both basal and 
nocturnal gastric secretion. They decrease the resistance of gastric mucosa to 
the irritant action of the gastric secretions, and produce or aggravate gastric 
ulceration. They are ulcer genic, the risk is doubled, bleeding and silent 
perforation of ulcers May occur41. 
1.12. Aggressive and Defensive Factors of The Gastrointestinal Tract42 
Peptic ulcer is precipitated by an imbalance of the aggressive and 
defensive factors of the GI tract 
Table No: 3 :Aggressive and defensive factors in GI tract for pepticulcer. 
AGGRESSIVE FACTORS DEFENSIVE FACTORS 
Gastric acid Mucus 
Pepsin Bicarbonate 
Bile Prostaglandins 
Acetylcholine Phospholipid membrane 
Histamine Cellular repair and migration 
Gastrin 
Medications 
Helicobacter pylori 
Mucosal blood flow 
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1.13. Approaches for the Treatment of Peptic Ulcer: 
1.13.1. Antacids 
Antacids have been used for conventional in the treatment of patients 
with dyspepsia and peptic-ulcer disorders. These are the important agent 
used to treatment for acid-peptic disorders up to discovery of H2-receptor 
antagonists and proton pump inhibitors. Now also continuously used in 
patients as a non-prescription drugs for cure of heartburn and dyspepsia. 
These agents having weak basic character and react with gastric hydrochloric 
acid to convert a salt and water. The mechanism of action of these agents are 
reduction of gastric acidity, promote the mucosal defence mechanisms by the 
stimulation of mucosal prostaglandin production. After ingestion of food, about 
45 m Eq/h quantity hydrochloric acid is released. A single dose volume of 156 
m Eq of antacid administration after the one hour from the food consumption 
fruitfully neutralizes gastric acid concentration for up to 2 hours. However, 
these capacity in different type of the branded formulations of antacids is 
significantly variable, it depends up on their dissolution rate, water solubility, 
kinetic of neutralization process, and the time of gastric emptying. 
Sodium bicarbonate (eg, baking soda, Alka Seltzer) combine faster 
with HCl to give carbon dioxide and NaCl. Neutralization of carbon dioxide 
affect the gastric distention and belching effect. The unaffected alkali is easily 
absorbed, may cause metabolic alkalosis at high doses or to patients with 
renal insufficiency syndrome. Sodium chloride absorption may elevate the 
fluid retention in patient’s having congestive failure, hypertension, and renal 
insufficiency. 
Calcium carbonate is sparingly soluble and reacts lower rate than 
sodium bicarbonate with HCl to give a molecule of carbon dioxide and CaCl2, 
it may produce belching or metabolic alkalosis. Higher doses of sodium 
bicarbonate or calcium carbonate alone calcium-containing dairy products can 
precipitate to hyperkalcemia, renal damage.  
Formulations having magnesium hydroxide or aluminium hydroxide 
slow reaction with HCl to produce magnesium chloride or aluminium chloride 
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and a molecule of water. Because no gas is formed so belching will not 
appear. Because unabsorbed magnesium salts may lead to osmotic diarrhoea 
and aluminium salts may lead to constipation, hence these substances 
commonly administered combined form in the branded proprietary products 
(eg, Gelusil, Maalox, Mylanta) to reduce patience compliance of bowel 
function the patients. These agents (magnesium and aluminium) are 
absorbed and bio transformed by the kidney so the patients having renal 
insufficiency should not use these agents for long term usage. 
All the antacids interfere the absorption among other medications by 
linking of the drug (retard its absorption) or by elevate the pH. It may affect the 
dissolution or solubility profile of drugs (commonly weakly basic or acidic 
drugs) is altered. Hence the antacids should not be administered with in two-
hour between tetracycline’s, fluoroquinolones, azoles, and iron ingestion. 
 
1.13.2. H2-Receptor Antagonists
53  
The H2 antagonist’s exhibit competitive binding in the parietal cell H2 
receptor and retard the basal and food-induced acid secretion in a normal, 
posology relate manner. They are specifically selective and should not infers 
H1 or H3 type receptors. The amount of gastric secretion and volume of the 
pepsin are also decresed.H2 antagonists retard the acid secretion induced by 
histamine, gastrin and cholinomimetic agonists by two mechanisms. One is 
the histamine secreted from ECL cells in gastrin or vagal stimulation have 
blocked through binding inside the parietal cell H2 receptor. Second, direct 
effect of the parietal cell by gastrin or acetylcholine may affect in suppress the 
acid secretions. It appears that reduced parietal cell cAMP levels attenuate 
the intracellular activation of protein kinases by gastrin or acetylcholine. 
Cimetidine, ranitidine, famotidine, nizatidine: 
The potencies of the four H2-receptor antagonists vary over a 50-fold 
range. When given in usual prescription doses however, all of the H2 
antagonists inhibit 60-70% of total 24-hour acid secretion. H2 antagonists are 
especially effective at inhibiting nocturnal acid secretion (which depends 
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largely on histamine) but have a lowest impact in meal mediated the acid 
release (this induced by gastrin, acetylcholine or histamine). Thus, they block 
more than 90% of nocturnal acid but only 60-80% of daytime acid secretion. 
Therefore, nocturnal and fasting intra gastric pH is raised to 4-5 but the impact 
upon the daytime, meal-stimulated pH profile is less. Recommended 
prescription doses maintain greater than 50% acid inhibition for 10 hours; 
hence, these drugs are commonly given twice daily. At doses available in 
over-the-counter formulations, the duration of acid inhibition is less than 6 
hours. 
1.13.3. Proton Pump Inhibitors (PPIs) 
54  
Proton pump inhibitors are pro drugs it is activated inside the acidic 
environment. After administration it enter in the GIT it enter by systemic 
circulation through absorption, again it transported to parietal cells and 
activated by acidic secretory pits. This place these drug activated via proton-
catalysed production of a tetracyclic sulphonamide. The activated form then 
drugs directly binds covalently via sulfhydryl groups of cysteines in the H+, K+-
ATPase pump, may cause deactivation of pump irreversible manner. Acid 
secretion start only, when the new pump molecules are synthesized and 
inserted into the luminal membrane, these agents have a prolonged duration 
of action (up to 24- to 48-hour) and retardation of acid secretions. 
Omeprazole55 can cause maximal inhibition of HCl secretion. Given 
orally in gastric juice-resistant capsules, it reaches parietal cells via the blood. 
In the acidic milieu of the mucosa, an active metabolite is formed and binds 
covalently to the ATP-driven proton pump (H+/K+ ATPase) that transports H+ 
in exchange for K+ into the gastric juice.  
Lansoprazole and pantoprazole produce analogous effects. The proton 
pump inhibitors are first-line drugs for the treatment of gastroesophageal 
reflux disease (GERD). 
1.13.4. Anticholinergics56, 57 
Anticholinergic drugs reduce in inter and post prandial secretion of 
gastric juice, since these phases are partially under cholinergic control. They 
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reduce basal acid secretion by about 50% and histamine and gastrin - 
induced secretion by 40%. They do not reduce food stimulated secretion. 
They inhibit gastric motility and prolong the gastric emptying time. 
Pirenzepine: This drug has selective antimuscarinic action on 
M1muscarnic receptors in the stomach.  
Propantheline and oxyphenonium are the other examples of this class. 
1.13.5. Mucosal Protective Agents 58 
Sucralfate contains numerous aluminium hydroxide residues.it is not an 
antacid after oral intake, sucralfate molecules reacted to form cross-linking in 
gastric secretion, forming a semisolid consistency  this attached to the 
mucosal layers hence it Protected from acid digestion, and it also helped 
ulceration due to the  pepsin, trypsin and bile acids related damage, improve 
ulcer wound more rapidly. Sucralfateis taken on an administered in empty 
stomach (one hour before meals and at bedtime). It is higher tolerated but it 
may release Al3
+ ions can lead constipation. 
1.13.6. Prostaglandin Analoges  
Misoprostol is a semi synthetic prostaglandin derivative with having 
higher stability compared to natural prostaglandin analogues, oral 
administration is compatible absorbed in local membrane and act as a 
prostaglandins synthesis promotes mucus production and inhibits acid 
secretion. Additional systemic effects (frequent diarrhoea; risk of precipitating 
contractions of the gravid uterus) significantly restrict its therapeutic utility. 
 
1.13.7. Colloidal Bismuth Compounds 59  
The bismuth may create coats ulcers and erosions, can produce the 
protective layer about acid and pepsin enzymes. It stimulate prostaglandin, 
mucus and bicarbonate secretion. This product reduces stool formation. It has 
direct antimicrobial effects and binds enterotoxins, direct antimicrobial activity 
against H pylori. 
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1.13.8. Ulcer Healing Drugs 
Carbenoxolone is a semisynthetic product of glycyrrhetinic acid, which 
derived from sap of liquorice root (belonging to the family succusliquiritiae) it 
stimulate mucus production and it has a mineralocorticoid like effect (inhibition 
of 11-β-hydroxysteroid dehydrogenase) that promote renal reabsorption of 
NaCl and water. It may, therefore, exacerbate hypertension, congestive heart 
failure or edemas.  
1.13.9. Eradication Of Helicobacter Pylori 
This bacteria plays a vital role for the pathogenesis of long term 
gastritis and peptic ulcer condition. The combine formulation of antimicrobial 
agents and proton pumb inhibitor (omeprazole) is proven effective. Some 
patients are tolerance to amoxicillin or clarithromycin, hence regimen is 
substituted with metronidazole. 
1.14. herbs helpful in antiulcer therapy18, 19 
Now a day’s world population have economical interest for the natural 
substance for the diagnosis and treatment of the traditional systems of 
medicine. Diet constriction and lifestyle change are the basis of Ayurvedic 
treatment regimen, with herbal medical formulas which will cure out 
therapeutic effect. Ayurvedic formulation contain many herbs (polyherbal 
formulation) having a high margin of safety and efficacy. Peptic ulcer is a 
serious health hazard occurs due to the imbalance between offensive factor 
(acid secretion, H.Pylori infection, bile, and increased free radical 
concentration) and impaired mucosal resistance factor (mucus, bicarbonate 
secretion, prostaglandins etc). Literature found that the conventional therapy 
have the serious adverse effects low patient complaince. 
Various herbal drugs like Shilajit, Ginger, Bael have been tried for their ulcer 
protective effectsand have promising results. Therefore, the search for an 
ideal antiulcer drug continues and has also been extended to herbal drugs for 
their better protection, easy availability, low cost and toxicity. 
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Acacia Arabica, Acacia catechu, Amaranth, Barberry (Berberis vulgaris), 
Black berry, Calendula, Dong Quai (Angelica sinensis), Ghee, Grapefruit 
(Citrus paradisi), Liquorice (Glycyrrhizaglabra), Olive oil, Piper betle, 
Plumbagozeylanica, Solon, Tea root extract. 
A peptic ulcer cause severe erosion of the gut lining inside the stomach, 
intestine or oesophagus. An ulcer occurs when the lining of these organs is 
corroded by an acid and digestive juices which are released inside stomach 
cell lines20. 
Ulcer may be lead to disintegration, loss and death of tissue as they 
erode the layers in the wall of the stomach or duodenum. There is an old 
saying in medicine, “No acid, and no ulcer’’ If the protective layer of mucus is 
insufficient or if there is inadequate dilution and buffering of acid gastric juices 
by swallowed food and the alkaline juices of the small intestine, it can result in 
ulcer. Hyperacidity is influenced by nervous system factors by anxiety, other 
emotional states and stress21. 
Bari ilayachi (Elettariacardamomum and Amomumsubulatum)Both drugs has 
gastro protective effect may be due to a decrease in gastric motility43. They 
cause relaxation of circular muscles which may protect gastric mucosa 
through flattening of the folds. This will increase the mucosal area exposed to 
narcotizing agents and release the volume of gastric agents on rugal crest. 
Such action has been postulated to play a role in cytoprotective effect of 
prostaglandins44. 
Black berry one of the most interesting substances that has been obtained 
from chili peppers and present in spicy plants such as ginger or black pepper 
is capsaicin. This substance acts on sensory neurons to stimulate their 
membrane receptors, predominantly vaniloid (VR)-1 receptors, and release 
various kinins such as substance P. When applied in large dose capsaicin 
destroys selectively C-fibre neuronal endings leading to inactivation of 
sensory nerves and the loss of all reflexes in which these nerves are involved. 
In smaller dose, capsaicin is the potent gastro protective agent and stimulant 
of gastric microcirculation45. 
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Chamomile is an herb that has been used traditionally as a mild sedative to 
relieve anxiety and in treating digestive disorders including peptic ulcers. 
Chamomile also may be effective in relieving inflamed or irritated mucous 
membranes of the digestive tract and in promoting digestion. Chamomile has 
a soothing action on the digestive system. Its gentle soothing action is 
beneficial in digestive disorders like indigestion, acidity and peptic ulcers. It is 
also high in the flavonoidapigenin-another flavonoid that has inhibited growth 
of H. pylori in test tubes46. 
Dong quai (Angelica sinensis) Animal studies suggest that dong quai may 
soothe ulcers, but studies in people are needed before a definitive conclusion 
can be drawn. 
Licorice (Glycyrrhizaglabra)Liquorice root has a high background in effect of 
soothing effect in the inflamed and damaged mucous membranes of the 
digestive tract. Licorice also protect the stomach and intestinal parts by 
increased production of mucin, which protects the lining of the HCl and other 
substances. According to Preclinical research, Flavonoids ofliquorice may 
also supressed the growth of H. Pylori47, 48. 
Marshmallow root (Althaea officinalis)For decades, marshmallow has been 
used in folk medicine to help cure gastric ulcers. The roots of the 
marshmallow contain mucilage, a gelatinous substance found in plants. When 
it comes into contact with water, this mucilage swells, forming a soft, 
protective gel. This is believed to provide a protective barrier against irritating 
substances that may aggravate ulcers. 
Tea root extract (Camellia sinensis)  Tea root extract might primarily decrease 
the leakage of plasma proteins into the gastric juice with strengthening of the 
mucosal barrier and increase in its resistance to the damaging effect of 
ethanol induced ulcer49. 
Turmeric (Curcuma longa) Constituents of Curcuma longa exert several 
protective effects on the gastrointestinal tract. A salt of curcumin, sodium 
curcuminate, was found to inhibit intestinal spasm, and p-tolymethylcarbinol, a 
turmeric component, was found capable of increasing gastrin, secretin, 
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bicarbonate, and pancreatic enzyme secretion. Turmeric has also been 
shown in rats to inhibit ulcer formation caused by stress, alcohol, 
indomethacin, pyloric ligation, and reserpine. This study demonstrated 
turmeric extract significantly increased the gastric wall mucus in rats 
subjected to these gastrointestinal insults50, 51. 
1.15. Screening Methods for Antiulcer Activity60, 61 
1.15.1. Pylorus ligation in rat (SHAY rat) 
This model is a simple and convention method for induction of gastric 
ulceration in the rat through ligature in the pylorus region, the ulceration is 
affected by accumulation of acidic juice inside the stomach. Ulcer index & pH 
of gastric content of treated animals are compared with control groups. 
Different cumulative group administration followed by dose - response curves 
establishment for ulcer formation can be measured in these method. 
 Female Wister rats weighing 150-170 g are starved for 48 hours having 
access to drinking water ad libitum. During this time they are housed single in 
cages in prevent coprophagy. Six animals are used per dose and as control 
groups. Under mild ether anaesthesia an incision is made at the abdominal 
midline. The pylorus is closed by using small nylon the higher supervision is 
required to avoid he damage of blood vessels inside the pylorus region. 
Grasping the stomach with instruments is to be meticulously avoided; else 
ulceration will invariably develop at such points. The abdominal wall are 
sutured through surgical procedure. The test sample are administrated 
through oral ingestion or injected subcutaneous route. The animals are placed 
for 19 hours in a suitable plastic container. Afterwards, these animals are 
sacrificed in CO2 anaesthesia. The abdomen is re ligated and a ligature is 
placed above the oesophagus region and closer to the diaphragm area. The 
stomach is replaced to a watch glass and the materials are collected in to a 
centrifugal tube. Above the longer curvature the stomach fully opened and 
pinned between a cork plates. The mucosal layer is observed with the help of 
a stereomicroscope. 
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1.15.2. Stress ulcer through immobilization stress 
Psychogenic factors, such as stress, produce a major role in etiology of 
gastric ulcers in human beings and animals. Hence not only antacids 
ingestion, anticholinergic, H2–antagonists, proton pump inhibitors treatment, 
and also psychotropic agents such as neuroleptics have also effective for the 
treatment. 
Groups of 6 female Wistar rats per dose of test drug and for controls 
weighing 150-170 g are used. Food and water are removed 24 hours before 
the experimental procedure. After oral or subcutaneous ingestion of the test 
substance or the placebo drug in animal’s extremities are fixed combine and 
the animals are tied in wire gauze. These animals are horizontally suspended 
in a dark room at 20oC for one day and last animals are sacrificed in CO2 
anaesthesia method. The stomach has been cut, fixed in a cork plate and the 
count and score the severity of ulcers by the help of video recorded stereo-
microscope. 
1.15.3. Stress ulcers by cold water immersion 
Cold water treatment of rats in during the restraint duration boost the 
appearance of gastric ulcers and reduce the time necessary immobilization 
process. 
 Groups of 8-10 Wister rats weighing 150-200 g are used. After oral 
administration of the test compound, the rats are placed vertically individual 
restraint cages in water at 22oC for 1 hour. These are removed, allowed to dry 
and inject Evans blue (30mg/Kg) intravenously through tail vein. After ten 
minutes, these animals are sacrificed by CO2 anaesthesia, stomachs was 
collected in Formal - saline (2%v/v) overnight storage about 24 hours. After 
that the stomachs are opened the greater curvature, washed via warm water 
and examined through 3-fold magnifier.  
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1.15.4. Indomethacin induced ulcers in rats 
Non-steroidal anti- inflammatory agents, like indomethacin and acetyl-
salicylic acid, produce a gastric lesions in human beings and in rodents by the 
inhibition of gastric cyclooxygenase leading for the formation of prostacyclin.  
Groups of 5-6 Wister rats weighing 150 - 200 g are used. The test drugs are 
administered orally in 0.1 % tween 80 solution 10 minutes before the oral 
indomethacin at a dose about 20 mg/kg (4 mg/ml dissolved in 0.1 % tween 80 
solution). Six hours later, the rats are euthanatized through CO2 anaesthesia, 
these animals stomach was removed and inject with Formol-saline (2%v/v) for 
storage about one days. After that the stomachs are opened the greater 
curvature, washed via warm water and examined through 3-fold magnifier.  
1.15.5.  Ethanol induced mucosal damage in rats  (Cytopotective activity) 
Intra gastric application of absolute ethanol is a reproducible method to 
produce gastric lesions in experimental animals. The lesions may be blocked 
by some drugs (ex:-prostaglandins). These protective activity opposite to the 
irritants are known as cytoprotective activity.   
 Male Wistar rats weighing 250 - 300 g are deprived of food 18 hours prior to 
the experiment but are allowed free access to water. During this time they are 
kept in restraining cages to prevent coprophagy. The rats are administered 
either are appropriate vehicle or the cytoprotective drugs, for example  a 
prostanoid, intra gastrically 30 minutes prior to administration of 1 ml absolute 
ethanol. Untreated animals are included as controls. One hour after 
administration of ethanol, the animals are sacrificed in CO2 anaesthesia and 
their stomachs exercised, cut along the greater curvature and gently rinsed 
under tap water. The stomachs are stretched on a piece of foam core mat, 
mucosal site up. The subjective scores of the treated tissues are recorded. 
1.15.6. Sub acute gastric ulcer in rats 
This is a method for producing standard sub-acute gastric ulcers in rats 
and for the quantitative evaluation of the healing process. 
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 Female Wistar rats weighing 120-150 g are fasted for 24 hours having 
access to water ad libitum in cages with wire sieves at the bottom. The rats 
are anesthetized with ether and a polyethylene catheter including a fine steel 
wire with a needle tip (1.2 mm diameter) at the lower end is orally inserted into 
the stomach. After the cannula reaches the gastric wall, the upper end of the 
steel wire is pressed in a definitive manner, so as to puncture the gastric wall. 
Each rat is kept in the same position during the intervention in order to 
localize the puncture at nearly the same region of the glandular part of the 
stomach. The test substances are administered orally, 30 minutes prior or 24 
hours after puncture. Free access to food and water is provided from 2 hours 
up to the end of the experiment. Each group consists of 8 - 15 rats. The 
animals are sacrificed by overdose of ether at definitive time intervals after 
puncture. The stomach is dissected and opened along the lesser curvature, 
extensively rinsed in tap water and fixed to the end of a polyethylene tube of 
10 mm diameter (plastic tip of an automatic pipette) in a position with the 
punched ulcer in the centre. The end of the tube with the gastric wall is 
suspended in a beaker containing physiological saline, and the pressure in 
the tube is gradually increased with a valve rubber ball connected to the other 
end of the tube.  The value of tension at which bubbles appear at the ulcerous 
gastric wall is noted. This value is termed as tensile strength and can be 
expressed in mm Hg. 
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  CHAPTER II 
                             2. LITERATURE REVIEW 
AshishPandey, et al, (2013)62 was reviewed the pharmacognastical 
,taxonomical and pharmacological use of desmostachyabipinnata. He 
reported it have Desmostachyabippinata is reported to have several medicinal 
properties for jaundice, menorrhagia, haemorrhoides, asthma, galactogogue, 
antihelicobactor, antidiarrhoeal and diuretic property as per literature. 
 
Audil Rashid et al,  (2001)63 was studied the in-vitro antibacterial effect of 
the of soil pollutants on soil incubating root-associated fungi. Roots of 
partheniumhysterophorous(L) subjected to fungal isolation of 
desmostachyabipinnata (L).Aspergillustype of was isolated from roots of both 
the plants. From this study 7 different fungal species were isolated and 
characterised. .The root extract of both plants were found to be have bacterial 
agent. 
 
K. Ashok Kumar et al,  (2010)64 studied the phytochemical analysis 
and antibacterial use of Desmostachyabipinnata whole plant extracts. The 
extracted essential oil obtained from the aerial parts of this species through 
hydro distillation and characterised via GC–MS analysis. From this study the 
extracts having 16 compounds representing 99.97% of the oils are appear as 
the principle secondary metabolite from this species. The in-vitro antibacterial 
screening was conducted through agar diffusion and broth dilution methods 
indicate the significant inhibitory effect against all four bacteria strains.  
 
Mohammed et al, (2009)65 investigate the potential in vitro 
antihelicobacter activity of selected Egyptian plants, focusing on the 
determination of the main component responsible for such activity. The main 
objective is to obtain a natural product have antihelicobacter activity. 
Antimicrobial screening for wild Egyptian medicinal plant extracts, revealed 
that five methanolic extracts have good antihelicobacter activity. 
Determination of MICs, revealed that the wild plant, Desmostachyabipinnata 
(DEM) extract proved to be the most active one, where its MIC was 40 μg/ml. 
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After fractionation of the DEM extract, ethyl acetate fraction exhibited 
excellent antihelicobacter activity. By further fractionation and purification, 
using TLC and column chromatography, a flavonoid compound was isolated, 
with MIC value of 62 μg/ml. The isolated compound was spectroscopically 
identified as 4`- methoxy quercetin-7-O-glucoside. DEM plant (available as a 
wild plant in Egypt) containing a flavonoid compound which possesses a good 
in vitro antihelicobacter activity. The isolated compound (Quercetin) might be 
useful as a chemo-preventive agent for peptic ulcer in H. pylori-infected 
individuals, after its clinical valuation. 
 
              Hafiz et al,  (2012)66 studied the crude aqueous-methanolic extract 
of D. bipinnata was evaluated through in vivo and in vitro experiments. The 
antidiarrheal study was conducted through mice against castor oil–induced 
diarrhoea, which will be conducted similar comparing toloperamide. These 
extract will be treated in gut preparations produced an effect similar like 
atropine-sensitive spasmogenic effect in rabbit jejunum up to 5 mg/mL, 
followed by a partial relaxation at 10 mg/mL. The maximum stimulant effect 
was comparable with the acetylcholine-induced maximum contraction and 
was similarly reproducible in guinea pig ileum preparation.   
 
Rajasekaranet al, (2015)67 evaluated the effect of the polyphenolic 
fraction of Desmostachyabipinnataroot extracts on tamoxifen induced liver 
necrosis in female Sprague-Dawley rat models.The roots of 
Desmostachyabipinnata were extracted through 70% methanol, and the 
polyphenolic fraction was isolated. Protection of BRL3A cells againstethanol-
induced damage was determined by 3-(4,5-dimethyl thiazol-2-yl)-2,5-
diphenyltetrazolium bromide assay. This study results indicate that it have the 
protective action against the tamoxifen induced hepatocytes. 
 
Gouriet al, (2014)68 studied hepatoprotective potential of dried 
powdered root extract of Desmostachyabipinnata against paracetamol- 
induced liver damage in wistar rat model. From this perspective aqueous 
extract of the roots of D.bipinnata at a dose of 100mg/kg and 200mg/kg 
wasadministered orally for 7 days. Silymarin at a dose 25mg/kg was used as 
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standard drug. On the 7th day of the experiment paracetamol was 
administered orally to induce toxicity. After the 24hrs of final drug 
administration, blood was collected and serum marker enzymes and bilirubin 
levels were determined. Animals pre-treated with aqueous extract of D. 
bippinata showed have the significant reduction in the elevated level of serum 
marker enzymes compared to paracetamolinduced liver damage in rat model. 
MedhaM.Hegde et al, (2010)69 studied the alcoholic and aqueous root 
extract of Desmostachyabipinnatafor antidiarrheal property in rats by castor 
oil induced diarrhoea and charcoal meal test atthe doses of 200 and 400 
mg/kg body weight. The alcoholic extract and to a less effective compared to 
the aqueous extract significantly. The phytochemical study of these extracts 
showed the presence of alkaloids, glycosides, flavonoids, tannins, 
phytosterol, terpenoids, polyphenolics, protein and carbohydrates. 
            Amani S. Awaadet al70 (2011) Five main flavonoid glycosides were 
isolated, for the first time, from the ethanol extract of Desmostachiabipinnata 
(L.)Stapf (Gramineae). They were identified as kaempferol(1), quercetin(2), 
quercetin-3-glucoside(3), trycin(4) and trycin-7-glucoside(5). The structure 
elucidation was based on UV, Electrospray ionization mass spectrometry 
(ESIMS), 1 H and 13 C NMR, proton- proton correlation spectroscopy ( 1 H- 
1 H Cosy), distortionless enhancement by polarization transfer (DEPT), 
heteronuclear single quantum coherence (HSQC), and heteronuclear multiple 
bond correlations spectrum (HMBC). The total extract (200 and 300 mg/kg) 
and two of the isolated compounds (trycin and trycin-7-glucoside.100 mg/kg 
each) showed a very promising antiulcerogenic activity with curative ratios; 
68.31, 70.54, 77.39 and 78.93%, respectively. 
Ashoka M. Shenoyet al,  (2012)71 The antiulcer activity of methanolic extract 
of Aeglemarmelos leaves was investigated by aspirin plus pylorus ligation 
induced as in gastric ulcers in rats, Indomethacin induced ulcer in rats, water 
immersion stress test induced ulcer in rats. In aspirin plus pylorus ligation 
model, Aeglemarmelos at doses of 200 and 400mg/kg produced significant 
reduction in gastric volume, free acidity, and ulcer index compared to control. 
In Indomethacin and water immersion stress test induced ulcer models both 
doses (200mg/kg & 400mg/kg) of Aeglemarmelos extract significantly reduced 
severity of ulceration.  
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CHAPTER III 
3. AIM AND OBJECTIVE 
GIT disease against few effective drugs available for modern therapy, it 
produce side effect during the treatment is worse than the condition of 
rebound acidity. as per the literature review selected plant that cure ulcer 
diseases so considerable interest has developed in the examination of these 
numerous plants remedies which are useful for antiulcer activity. So it is 
necessary to find new drugs of importance in antiulcer effect with fewer side 
effects. Moreover it is necessary to required scientific validation traditionally 
using medicinal plants on various systems such as Ayurvedic Siddha Unani 
systems.  
  In our study Desmostachyabipinnata plant extracts its phytochemical 
investigation will be a useful tool for the identification and authentication of the 
plant for industrial and further research purpose, which will be related to the 
antioxidant activity. Antioxidants, which can scavenge free radicals, have an 
important role in pharmacological systems. Antioxidants are emerging as 
prophylactic and therapeutic agents. Hence, antioxidant was also evaluated 
for the potent extract. And now I have under taken the study of evaluation 
anti-oxidant and antiulcer activity of Desmostachyabipinnata plant extracts by 
using invivo and invitro methods  
 To select plant based on their ethnomedical uses and preparation 
of their extracts.  
 To screen phytochemical profile. 
 To screen the selected extract for antioxidant using various invitro 
methods  
 To screen the potent plant extract for their invitro antioxidant, 
 To evaluate invivo antiulcer activities by NSAIDs induced animal 
model. 
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                                                CHAPTER IV 
                                         4. PLAN OF WORK 
 
                                                  Literature review 
Selection of plant 
Collection of plant  
Authentication of plant 
Powdered the whole plant 
Extraction of powered plant 
 
Phytochemical Screening               Pharmacological Screening 
  Alkaloids    
 Saponins                                                  
 Tannins                   invitro antioxidant screening
   
 Flavonoids        
                                                                                 Acute toxicity studies 
 Terpeniods                                   
Measuring body weight                                          Anti ulcer activity study 
 Proteins etc., 
 
        
Result and discussion 
 
Conclusion 
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                                                  CHAPTER V 
 
5. PLANT PROFILE 
 
 Figu. No : 3 : Photograph of Desmostachyabipinnata73 
 
5.1. Taxonomical Classification74 
Table No : 4 : Taxonomical classification of Desmostachyabipinnata 
Kigdom Plantae 
Division Magnoliphyta 
Class Monocotyledonae 
Order Poales 
Family Poaceae 
Genus Desmostachya 
 
Species 
 
D. bipinnata 
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5.2. Vernacular Names75 
Table No : 5 : Vernacular names of Desmostachyabipinnata 
 
 
 
 
 
 
 
5.2. Distribution 
Global Distribution : South Asia and Europe 
5.3. Plant Description76 
 A rhizomatous perennial of dry areas with an extensive system of 
rhizomes 2–3 mm thick at 0.1-02mdeep.The leafsare coarse, narrow, 
tough, up to 0.5 m length.Culms with glossy yellow leaf sheaths at the 
rhizomatous perennial of dry areas with an extensive system of rhizomes. 
Leaves are coarse, narrow, tough, up to 50 cm long. The whole plant 
materials are useful for the symptoms of different diseases. 
Desmostachyabippinata is indicated by several medicinal treatments for 
jaundice and other gastro intestinal disorder, Plant is a common weed 
plant mainly cultivated Northern parts of India. From these plants lot of 
chemical constituents have isolated including tannins, flavanoids, 
terpenoids, carbohydrates and essential oils.. The alcoholic and aqueous 
extract are useful of this plant for several diseases.  
5.4. Chemical constituents 
 The sample of essential oil is collected from the aerial parts of the 
plant via hydro distillation process. The literatures indicates it contains 16 
Tamil Kusa, Taruppaipullu 
Kannada Darpha 
Malayalam 
 
Darphapullu, Kusa 
 
English Sacrificial grass 
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compounds representing 99.97% of the oils: camphene (16.79%), 
isobornyl acetate (9.92%), tricyclene (4.30%), (+,-) trans-2,6-gamma-Irone 
(2.21%), Caryophyllenediepoxide (12.29%) , β-eudesmol (11.16%) 
Eseroline (25.15%) and Calarene(3.48%) appear as the main 
components.[3] Plant contain xanthenes also.[2]The plant contain 
flavonoids and carbohydrates also, 
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CHAPTER VI  
6. MATERIALS & METHODS 
 
6.1. Collection and Authentication of Plant 
Desmostachyabipinnata plan twas procured from the Botany Central 
council for Research in Ayurvedia and Siddha Govt of India and authenticated 
by Chelladurai.V research officer Botany Central council for Research in 
Ayurved and Siddha Govt of India. CERTIFICATE NO:UWAN/344/16  
6.1.1. Extraction Procedure78 
Preparation of Desmostachyabipinnata whole plant extract. 
The plants were initially collected from the soil body and rinsed with 
distilled water and shade dried and then homogenized into fine powder and 
stored in air tight bottles. A total of 10 g of air dried powder was weighed and 
was placed in 100 mL of organic solvents (methanol and ethanol) in a conical 
flask and then kept in a rotary shaker at 190-220 rpm for 24 h. And then it was 
filtered with the help of muslin cloth and the solvent was evaporated by 
solvent distillation apparatus to make the final volume of one-fourth of the 
original volume, giving a concentration of 40 mg/mL. It was stored at 40 °C in 
air tight bottles for further studies. 
6.2.  Phyto Chemical Screening79-80 
The plant may be containing the following compound such as 
carbohydrate, protein, and lipids. That is utilized as food by man. It also 
contains the compound like. Tannins, Glycosides, alkaloids. Volatiles oils. The 
compound that is responsible for lots of medicinal properties  
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6.2.1. Test for carbohydrates  
 6.2.1.1. Molisch test 
  The sample powdered was added with 1 ml of alpha napthol 
solution along with conc Sulphuric acid solution in the test tube reddish 
colour was produced at the junction between 2 liquid  
 6.2.1.2. Fehling test 
  To the sample powder was added with both Fehling A and 
Fehling B solution and placed in the water bath for a sufficient time. 
This shows the brick red colour.  
 6.2.1.3. Benedicts test 
  To the sample powder add 8 drops of benedict’s reagents and 
Boil the sample vigorously for 5 min it shows the red ppt.  
6.2.2. Test for alkaloids 
 To the small of stored powder (sample) was taken and add few drops 
of hydrochloric acid and filtered. The filtered was tested with various 
alkaloid agents. 
 6.2.2.1. Mayer’s reagents 
  To a small of above filter add small quantity of Mayer’s reagent 
to form cream precipitate.  
 6.2.2.2. Dragendorffs reagents 
  From the above filter add small amount of Dragendorffs 
reagents it forms a orange brown precipitate.  
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6.2.3.  Test for flavonoids 
  To the filter of the plant extract add 5 ml of dilute ammonia 
solution and followed by the addition of concentrated sulphuric acid. It 
forms a yellow colour.  
6.2.4. Test for steroids. 
 6.2.4.1. Salkowski test 
  Few amount of plant extract was mixed with chloroform and the 
same volume of sulphuric acid is added on it. Cherry red colour was 
obtained in the chloroform layer.  
          6.2.4.2. Libermannburchard test 
  The extract is dissolved in 2 ml of chloroform 10 drops of acetic 
acid and conc. Sulphuric acid were added. Now the solution becomes 
reddish colour then it turns to bluish green colour.  
6.2.5. Test for tannins 
 From few amount of plant extract is treated with vanillin hydrochloric 
acid reagent. It forms, pink or red colour due to the formation of 
phloroglucinol. 
6.2.6. Test for protein. 
 6.2.6.1. Millon’s reagents 
  Mellon’s reagents (mercuric nitrate in nitric acid containing a 
trace of nitrous acid) usually yields a white precipitate on addition to a 
protein solution which turns red on heating.  
6.2.6.2.  Ninhydrin Test 
   From the sample solution add 2 drops a freshly prepared 
0.2% ninhydrine reagent was added to the extract and heating. 
Development of blue colour may indicate the presence of peptide, 
amino acid (protein). 
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6.2.7. Test for glycosides 
 6.2.7.1. Keller- killani test 
  From the small quantity of small powder acetic acid was 
dissolved and adds few drops of ferric chloride and transferred to the 
surface of concSulphuric acid. At the junction, reddish brown colour 
was formed, which gradually becomes blue indicates the presents of 
cardiac glycosides. 
6.2.8. Test for saponins 
 6.8.1. Foam test 
 1 ml of extract solution is diluted separately with distilled water to 20 ml 
and shaken in a graduated cylinder for 15 minutes. A 1 cm layer of foam 
indicates the presence of Saponins. 
6.3.  In Vitro Antioxidant Activities                                                                                            
  6.3.1  Superoxide  Radical Scavenging Activity81 
6.3.1.1. Principle 
The superoxide anion radical scavenging activity was determined by 
nitro blue tetrazolium (NBT) reduction method of Mc Cord and Fridovich 
(1969). The assay is based on the ability of drug to inhibit the reduction of 
nitro blue tetrazolium (NBT) by Superoxide, which is generated by the 
reaction of photo reduction of Vitamin C within the system. The superoxide 
radical thus generated reduce the NBT to a blue coloured complex. 
6.3.1.2. Reagents 
 Nitro blue tetrazolium (NBT)   -  1.5nm  (12.3mg/10ml) 
 Vitamin C                     -   0.12µm  (4.5mg/100ml) 
 NaCN/EDTA         -   0.0015% NaCN in 0.1M EDTA 
 Phosphate buffer         -   0.06M  ( pH 7.8 ) 
 
       Page 40 
 
 
6.3.1.3  Procedure 
The reaction mixture contained EDTA (0.1 M), 0.3mM NaCN, Vitamin C 
(0.12mM), NBT (1.5 n moles), Phosphate buffer (67mM, pH 7.8) and various 
concentrations of the alcoholic extract in a final volume of 3ml. The tubes 
were illuminated under incandescent lamp for 15min. The optical density at 
560 nm was measured before and after illumination. The inhibition of 
superoxide radical generation was determined by comparing the absorbance 
values of the control with that of alcoholic extract and fraction-IV. Vitamin C 
was used as positive control. The concentration of fraction-IV required to 
scavenge 50% superoxide anion (IC50 value) was then calculated.   
CALCULATION  
    % inhibition   =     
𝑶𝑫࢕ࢌ𝒄࢕࢔࢚࢘࢕࢒−𝑶𝑫࢕ࢌ࢙𝒂࢓࢖࢒ࢋ𝑶𝑫࢕ࢌ𝒄࢕࢔࢚࢘࢕࢒    × 100 
6.3.2. DPPH Radical Reducing Activity82 
6.3.2.1. Principle 
It is a rapid and simple method to measure antioxidant capacity. It 
involves the use of free radical, DPPH (2, 2- Diphenyl - 1- picrylhydrazyl) 
(Aquino et al, 2001). The odd electron in the DPPH free radical gives a strong 
absorption maximum at 517nm and is purple in color. The color turns from 
purple to yellow when the odd electron of DPPH radical becomes paired with 
hydrogen from a free radical scavenging antioxidant to form the reduced 
DPPH-H. The resulting decolourization is stoichiometric with respect to the 
number of electrons captured. 
6.3.2.2. Reagents 
 DPPH  -   3mg in 25ml methanol (stored in dark bottle) 
 Methanol        
6.3.2.3. Procedure 
Freshly prepared DPPH (187 µl) was taken in different test tubes protected 
from sunlight. To this solution added different concentrations (0, 25, 50, 
75,100,150,200µg/ml) of alcoholic extract and fraction-IV. The volume was 
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made up to 1ml with methanol. Keep the tubes in dark and after 20 min 
absorbance was measured at 515nm. Methanol was used as blank and 
vitamin C was used as positive control. The concentration of test materials to 
scavenge 50% DPPH radical (IC50 value) was calculated from the graph 
plotted with % inhibition against Concentration. 
Calculation  
   % inhibition   =    
𝑶𝑫࢕ࢌ𝒄࢕࢔࢚࢘࢕࢒−𝑶𝑫࢕ࢌ࢙𝒂࢓࢖࢒ࢋ𝑶𝑫࢕ࢌ𝒄࢕࢔࢚࢘࢕࢒    × 100 
 
6.4. Pharmacological Screening 
6.4.1. Animals 
The albino rat (average body weight 200-300g), used from in house 
laboratory. The animals were maintained under standardized environmental 
conditions (22-28oC , 60-70% relative humidity, 12 hr dark/light cycle) in 
animal house, Department of uwin life science malappuram. The animals 
were provided with standard mouse chow (SaiDurga Feeds and Foods, 
Bangalore, India) and water ad libitum. All animal experiments were 
conducted during the present study got prior permission from Institutional 
Animal Ethics Committee (IAEC approved) and following the guidelines of 
Committee for the Purpose of Control and Supervision of Experiments on 
Animals (CPCSEA) constituted by the Animal Welfare Division, Government 
of India (No:-KU/IAEC/M.pharm/167). 
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ACUTE TOXICITY STUDIES  (Dose Fixation83) 
ACUTE TOXICITY STUDY 
Experimental Protocol 
 
Guideline   :  OECD – 420-fixed dose method 
CPCSEA Reg. No  : KU/IAEC/M.Pharm/167 
Test    : Limit test 
Species   :   Rattusnorvegicus 
Strain    :  Albino Wistar rats 
Number of animals  :  24 
Sex    :  Male/female 
 Dose    : 5, 50, 300, 2000 mg/kg 
Route of administration :  Oral 
Duration :  3hr close observation, followed by 
14 …….  days observation 
Table No : 6 :  Experimental Design for Acute Toxicity Studies 
 
 
 
 
 
 
 
6.4.2. Study Design 
Test animal – 6-8weeks old Adult Wistar rats of male and female, nulliparous 
and non-pregnant animals were obtained from centralized animal house from 
uwin life science malappuram and acclimatized to holding for 1 week prior 
dosing. 
Group Dose(mg/kg) 
Group I 5 
Group II 50 
Group III 300 
Group IV 2000 
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Housing conditions 
Temperature – The experimental animal room temperature maintained at 
22°C±3°C OECD guideline-423, 2001. These ranges are designed to allow 
homeotherms to maintain metabolic rate or to be within their thermo neutral 
zones. Because, temperature below the recommended range leads to 
increased food intake, increased energy expenditure but decrease in 
efficiency. In contrast, temperature above the recommended range leads to 
decreased food intake, decreased weight and decreased energy expenditure. 
Toxicity can vary with temperature might increase with linearity with 
temperature. 
Humidity – The relative humidity maintained at 40%-60% preferably not 
exceeds 70% (OECD-423, 2001).The relative humidity below the 
recommended range can develop lesions such as ring tail and food 
consumption may be increased. 
Light – 12-12 hours, Light/dark cycle. Appropriate lighting and light cycle play 
a key role in maintaining the physiology and the behaviour rat. Light provided 
for adequate vision and for neuroendocrine regulation of diurnal and circadian 
cycles (CPCSEA guidelines for laboratory animal facility 2003). 
Light intensity – The light intensity maintained at 325 lux approximately 1m 
above the floor. Consideration of variations in light intensity, for the 
arrangement of animals on cage rack for toxicology study is necessary.  
Caging – Polypropylene cages with solid bottom and walls. Lids made up of 
stainless steel grill capable of holding of both feed and water.Feeding 
condition – Sterile laboratory feed (ad libitum) and RO water bottles daily. 
Feed – Brown colored chow diet 
Drug administration – Animals were fasted for 12hour prior to dosing on 
day 0. Treatment rats were dosed by oral gavages, using a curved and ball 
tipped stainless steel feeding needle, with 20% gum acacia solution.  
Clinical observations – All rats were monitored continuously for 4 hour after 
dosing for signs of toxicity. For the remainder of the 14 days study period, 
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animals were monitored and any additional behavioural or clinical signs of 
toxicity. Animal’s body weight was measured prior to dosing and on days 7 
and 14.On all animals were killed and at the end of the study LD50 value was 
established. Clinical observations and gross pathological examination was 
carried out. 
6.4.3. Aspirin Induced Ulcer84 
Table No : 7 : Dose dependent studies: (Animal: rats) 
SI 
NO 
 
DRUG 
 
 
DOSE 
ROUTE 
OF 
 
NO. 
OF 
ANIMALS 
PARAMETERS 
FOR 
STUDY 
 
1. 
Control 
(water) 
 
---------- 
Oral 
administration 
 
6 1.Ulcer index& 
Ulcer score 
2.Total acidity 
3.Acid volume 
4.pH 
5.Glutathione 
6.Total protein 
 
 
2. 
Standard 
(famotidine) 
 
3mg/kg 
 
Oral 
 
6 
3. AEDB 
100mg/
kg 
Oral 6 
 
4. 
AEDB 
 
200mg/
kg 
 
Oral 
 
6 
5 AEDB 
400 
mg/kg 
Oral 6 
 
6.4.3.1.  Ulcer index& ulcer score 
 Procedure 
1. Animals in the group of aspirin induced ulcer were starved for 36 hours 
having access to drinking water ad libitum. 
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2. 1ml of 80% ethanol would be administered orally. Famotidine is given 
to one group and leaf extractsto the other groups 1 hour before the 
administration of ethanol. 
3. After 2 hours of ethanol administration, animals will be sacrificed by 
overdose of ether. 
4. The stomach was removed and fixed on a cork plate and the number of 
and severity of ulcers was registered with a stereo-microscope using 
the following scores.  
Severity score 
  0 = Normal coloured stomach 
 0.5 = Red colouration 
  1 = Spot ulcer 
 1.5 = Haemorrhagic streaks 
  2 = Ulcers ≥ 3 but ≤5 
  3 = ulcers > 5 
Calculation 
Ulcer index is determined by using following formula; 
UI = UN+US+ UP X 10-1 
Where, 
 UI = ulcer index 
UN = average of number of ulcers per animal 
US = average of severity score 
UP = percentage of animal suffered ulcer 
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6.4.3.2.  Determination of total acidity86 
Principle 
A known amount of gastric residue was titrated with 0.1 N sodium 
hydroxide to a pH of 3.5. If pH meter is not available, add two drops of 
Topfer’s reagent which changes to a salmon colour when all the free 
hydrochloric acid is neutralized. The total acidity however was determined by 
titration using phenolphthalein as indicator. 
Reagents: 
(a) Sodium hydroxide solution (0.1N NaOH): Stock Sodium hydroxide 
solution (0.1N NaOH) was diluted ten-folds. Alternatively, 4g of NaOH was 
dissolved in fresh distilled water and made up to 1000 ml.  
(b) Phenolphthalein solution (1% alcoholic): 1 g of phenolphthalein was 
dissolved in 100 ml of 95% alcohol.  
(c) Topfer’s reagent (Dimethylaminoazobenzene), 0.5% alcoholic 
solution: 0.5 g of Topfer’s reagent was dissolved in 100 ml of 95% alcohol.  
Procedure: 
1. 10ml of gastric juice specimen was transferred in a porcelain 
evaporating dish.  
2. 1-2 drops of Topfer’s reagent is added.  
3. A colour change was observed; a bright red colour appears if free 
hydrochloric acid is present. 1-2 drops of phenolphthalein was added to 
the gastric juice with Topfer’s reagent.  
4. Titrated with 0.1 NaOH from a burette, mixing was done after each 
addition until the last trace of red colour disappeared and was replaced 
by a canary yellow colour.  
5. The numbers of millilitres of NaOH used was read from the burette. 
This represents the amount of free hydrochloric acid.  
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6. The titration was continued until the red colour of phenolphthalein 
appeared (deep pink), titrated to the point at which the further addition 
of alkali did not deepen the colour.  
7. Reading was taken (ml NaOH) for total acidity.  
calculation 
                                             Y = ml of 0.1 N NaOH x 10 
Where, 
   Y= Total acidity (mEq/L) 
6.4.3.3. Acid volume 
Procedure 
1. Animals in the group of aspirin induced ulcer were starved for 36 hours 
having access to drinking water ad libitum. 
2. 1ml of 80% ethanol would be administered orally. Famotidine is given 
to one group and plant extracts to the other groups 1 hour before the 
administration of ethanol. 
3. After 2 hours of ethanol treatment, animals will be killed by overdose of 
ether. 
4. The stomach was removed and the contents were drained into a 
graduated centrifuge tube through a small nick along the greater 
curvature. 
5. The volume of the juice was measured. 
6.4.3.4. pH 
Procedure 
1. Animals in the group of ethanol induced ulcer were starved for 36 
hours having access to drinking water ad libitum. 
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2. 1ml of 80% ethanol would be administered orally. Famotidine is given 
to one    group and AEDB to the other groups 1 hour before the 
administration of ethanol. 
3. After 2 hours of ethanol administration, animals will be sacrificed by 
overdose of ether. 
4. The stomach was removed and the contents were drained into a 
graduated centrifuge tube through a small nick along the greater 
curvature. 
5. The tubes were centrifuged at 3000 rpm for 10 minutes and the 
centrifuged samples were decanted and analysed for pH (using digital 
pH meter, Type DPH – 100- Data instruments). 
 
6.4.3.5. Estimation of glutathione87 
Reagents  
DTNB reagent (5-5 dithiobis-2 nitrobenzoic acid): 39.6 mg of DNTB 
dissolved in 100 ml of 1 % of sodium citrate solution.  
Trichloroacetic acid (TCA). 
Procedure   
The mucosa of glandular stomach was removed by scraping with a 
blunt knife and 10% homogenate was prepared. The homogenate was 
precipitated with 25% trichloro acetic acid (TCA) and centrifuged. The 
supernatant was taken for GSH estimation using freshly prepared DTNB 
solution. The supernatant was taken for GSH estimation using freshly 
prepared DTNB solution. The intensity of the yellow colour formed was read 
at 412 nm parallel blank for each sample without reagent was run.  
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Calculation 
The amount of Glutathione was determined using molar extinction coefficient. 
Calculate the enzyme activity by the following formula:  
                                                           A = Є. b. c 
Where,       A = Absorbance of the solution. 
 Є = molar extinction coefficient. 
   b = path length of the light. 
c = Concentration of absorbing solute. 
6.4.3.6. Estimation of total protein88 
Biuret method: This method is easy to follow and provide accurate 
results. 
Principle 
Proteins and peptides react with alkaline copper tartrate solution to 
give a violet coloured complex. The intensity of the final colour complex is 
measured calorimetrically at 540 nm and is proportional to the concentration 
of the total protein in the specimen under test. Under carefully controlled 
conditions this method can prove to be very useful but the reagents must be 
prepared carefully. 
Reagents 
a) Working biuret solution.        
(b) Saline (NaCl, 0.85%w/v in water): 8.5 g of sodium chloride was 
dissolved in about 800 ml of water and placed in a one litre volumetric 
flask. The solution was brought up to the 1000 ml mark with water and 
mixed by inversion. The solution was kept in a stoppered glass bottle. 
(c) Standard protein solution: The value of the protein concentration 
was in the range of 6 to 8 g protein per 100 ml. 
Procedure 
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1. Three test tubes were set up marked as T, S and B for test, standard and 
blank respectively. 
2. 5 ml of working Biuret reagent was pipetted out into the above test tubes. 
3. 100µL of undiluted specimen and standard was added in T and S tubes 
respectively, and 100µL of water in tube B. 
4. Contents were mixed thoroughly and incubated for 15 minutes at 370C in a 
water bath or alternatively for 30 minutes at room temperature. 
5. Absorbance of the test and standard was measured against the blank at 
540nm. The readings were completed within one hour. 
 
 
 
 
 
Calculation 
 
 
Where, 
At = Absorbance of testAs = Absorbance of standard 
 
 
 
 
 
 
 
Total protein concentration in test specimen (g/dL) = (A t/A s) x 6 
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CHAPTER VII 
7. RESULTS AND DISCUSSION 
7.1. Soxhlet Extraction Of  Desmostachya Bipinnata   
 The percentage yield of the Desmostachyabipinnata was 
found to be 20.88 %w/v. 
Table No : 8 : Extraction of  Desmostachyabipinnata 
 
Preliminary phyto chemical screening. 
Alcoholic Extract of Desmostchyabipinnata was subjected various 
chemical tested as per the standard methods for the identification of the 
various constituents. The result if this phyto chemical analysis is listed 
below. 
Plant 
Part 
used 
Method of 
Extraction 
Solvents 
Percentage 
Yield (%W/V) 
 
Desmostachyabipinnata  
Whole 
plant 
Maceration 
Ethanol 
(95%) 
20.88 
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7.2. phytochemical evaluation  
 The preliminary phytochemical screening of whole plant extracts 
indicate in presence of flavonoid, alkaloid, proteins,amino acids and 
terpenoids, fixed oil and glycosides may accounts antioxidant and anti-ulcer 
potential.  
7.2.1. Test for Proteins 
I. Biuret Test:  
 A violet colour indicates the presence of proteins. 
II. Xanthophoretic Test:  
Orange colour indicates the presence of aromatic acids. 
III. Lead acetate Test: 
 A white precipitate indicates the presence of proteins. 
7.2.2. Test for Amino acids 
  I. Ninhydrin Test: 
A  blue colour indicates the presence of proteins, peptides or amino acids. 
7.2.3. Test for Fats and Oils  
I.  Red globules in the section when viewed under the microscope show the 
presence of fats or oils. 
 
7.2.4. Test for Cardiac glycosides 
I. Keller-killiani Test:  
 At the junction, reddish brown colour was formed, which gradually 
becomes blue indicates the presence of cardiac glycosides. 
7.2.5. Test for Flavonoids 
I.  On addition of sulphuric acid solution gives deep yellow solution. 
II. Heat the test solution with Zinc and HCl, pink to red colour observation shows 
the presence of flavonoids. 
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7.2.6. Test for Alkaloids 
I. Dragendroff’s Test:  
 An orange red coloured precipitate indicates the presence of alkaloids. 
II. Wagner’s Test:  
Reddish brown coloured precipitate indicates the presence of alkaloids. 
III. Mayer’s Test:  
 A dull white coloured precipitate indicates the presence of alkaloids. 
7.2.7. Test for Phenolic compounds and Tannins 
I.  The respective observations may be deep blue black colour, white 
precipitate, white precipitate, decolouration of bromine water showing the 
presence of tannins and phenolic compounds. 
 
 Table No : 9 : Qualitative phyto chemical screening of AEDB 
PLANT 
CONSTITUENT 
INFERENCE 
Ethanol Extract 
Carbohydrate - 
Alkaloids + 
Flavonoids + 
Proteins and 
amino acids 
+ 
Glycosides + 
fixed oil + 
Terpenoids + 
Volatile oil - 
Tannins - 
 
“+” Presence,“-” Absence. 
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7.3. In Vitro Antioxidant Activities 
7.3.1. Effect of superoxide radical scavenging activity:  
Superoxide generated in the photo reduction of vitamin C was 
effectively inhibited by the addition of varying concentrations (0-
14L/ml). The concentration of the AEDB needed to scavenge 50% 
superoxide anion (IC50) was found to be 8 g/ml (figure 4) Vitamin C 
which was used as a positive control had an IC50 value of 4.5 g/ml. 
Table No : 10 : Effect of AEDB on Superoxide in vitro Radical 
Scavenging Activity 
 
Results are mean ± SD of three individual experiments 
 
 
 
 
 
 
Concentration 
(µg/ml) 
Absorbance Percentage inhibition 
Ethanol 
extract 
Vitamin C 
Ethanol 
extract 
Vitamin C 
0 0.78±1.22 0.78±1.5 0±0.00 0±0.00 
2 0.72±2.31 0.54±3.5 7.6±1.35 30.76±0.71 
4 0.65±3.1 0.41±0.78 16.6±4.71 47.43±1.79 
6 0.58±1.27 0.36±1.55 25.64±3.6 53.84±2.53 
8 0.54±1.72 0.28±2.3 30.76±1.55 61.94±4.22 
10 0.47±5.5 0.19±3.6 39.47±2.44 75.64±1.67 
12 0.41±3.7 0.14±2.3 47.43±3.39 82.05±2.36 
14 0.35±1.78 0.11±3.2 55.12±0.67 85.89±0.37 
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Fig. No : 4 : Effect of AEDB on Superoxide in vitroRadical 
Scavenging Activity 
 
 
7.3.2. Effect of AEDB on DPPH radical reducing activity : 
The DPPH radical was effectively scavenged by AEDB. A dose dependent 
reduction of was observed within the range of concentrations (0-100g/ml) of 
reaction system The IC50 value of various type of extracts was form the figure 
no -5. Vitamin C which was used as the positive control exhibited an IC50 
value of 21.6 g/ml. 
The antioxidant screening shows that that it showed reducing power to 
DPPH radicals. But the efficiency showed that far below from Vitamin C. The 
concentration of the AEDB needed to scavenge 50% superoxide anion (IC50) 
equal to that of standard hence the  plant extract have the significant 
antioxidant activity 
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Table No : 11 : study of in vitro DPPH Radical Scavenging Activity 
Results are mean ± SD of three individual experiments. 
 
Fig. No : 5 :DPPH radical reducing activity of AEDB and vitamin C. 
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Concentration 
DPPH free radicle scavengering Activity 
AEDB
Vitamin C
Concentration 
(µL/ml) 
Absorbance Percentage inhibition 
Ethanol 
extract 
VitaminC 
Ethanol 
extract  
VitaminC 
1 0.694±0.21 0.58±1.23 0.5±0.71 15.8±2.3 
10 0.676±1.31 0.487±3.5 4.35±.56 29.9±2.9 
20 0.640±3.22 0.361±1.23 9.03±0.78 49±5.6 
30 0.60±1.52 0.121±1.5 14.2±1.3 67.8±4.9 
40 0.566±4.35 0.101±3.2 19.2±1.27 87.3±4.3 
50 0.530±2.33 0.046±4.2 23.4±1.32 97.3±4.2 
60 0.461±3.5 0.06±4.9 29.2±.79 96.1±3.2 
70 0.459±3.6 0.05±4.1 36.3±0.96 96.2±4.56 
80 0.40±4.6 0.05±0.22 41.9±0.95 96.2±4.32 
90 0.36±2.5 0.04±0.3 48.13±1.32 97.5±3.78 
1OO 0.327±3.72 0.03±.52 54.23±1.56 98.3±3.96 
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7.4. Pharmacological Study 
 
7.4.1. Acute Toxicity Studies 
 Acute toxicity studies on the albino rats show no morality at a dose of 
2000mg/kg of AEDB during a time period of 14 days. In this study, NOAEL 
were seen in the rats. This help to predict that it does not contain any type of 
toxicity and it is fully safe for therapeutics uses. So 200 mg/kg between (1/10th 
dose) of ethanol extract were selected of that dose for the further study. 
7.4.1.1. Anti-Ulcer Study 
Antiulcer activity of Alcoholic Extract of Desmostachyabipinnata 
(AEDB) on Aspirin induced rat model and it was found to be it has shown 
significantly    increased anti-ulcer activity by increasing doses. The maximum 
effect was observed at administration of 400mg/kg of AEDB Hence this study 
was dose depended. The result was shown Table 12 . 
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 Fig. No : 6 : Photographs Showing Aspirin Induced Gastric Ulcers                              
 
 
 
         
 
  
Control Standard 
  
Low dose 
 
High Dose 
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Effect of AEDB on Ulcer Index on NSAID induced Ulcer model 
AEDB showed reduction in ulcer index at all doses tested when 
compared with control as reflected by the ulcer index values. The ulcer index 
value of group I which served as control (water) was 4.11±0.25. The total 
acidity of group III (100mg/kg), group IV (200mg/kg) and group V (400mg/kg) 
was 3.32±0.28, 2.29±0.21, 1.89±0.11 respectively, as shown in Table 12. 
Famotidine, the reference standard (group II) had total acidity 1.68±042, as 
shown in Table 12. Dose has been increased the ulcer index significantly 
reduced which showing the table no:12  
 
Table No : 12 : Effect of AEDB on Ulcer Index on NSAID induced 
Ulcer model 
S.No Treatment Dose Ulcer Index 
 
1 
 
Control 
(water) 
 
- 
 
4.11±0.25 
 
2 
 
Famotidine 
 
3mg/kg 
 
1.68±0.42** 
 
3 
AEDB 
 
 
100mg/Kg 
 
3.32±0.28 
 
4 
AEDB 
 
 
200mg/Kg 
 
2.29±0.21* 
 
5 
AEDB 
 
400mg/Kg 
 
1.89±0.11** 
         AEDB - Alcoholic Extract ofDesmostachyabipinnata 
                       **P<0.001, *P<0.05, compared with control 
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Fig. No : 7 : Effect of AEDB on Ulcer Index on NSAID induced Ulcer                      
model 
 
 
 
 
 
Effect of AEDB on Total Acidity on NSAID induced Ulcer model 
 
 AEDB showed reduction in total acidity at all doses tested when 
compared with control as reflected by the total acidity values. The total acidity 
of group I which served as control (water) was 73.14±1.13. The total acidity of 
group III (100mg/kg), group IV (200mg/kg) and group V (400mg/kg) was 
75.6±0.22, 67.06±0.516, 40.20±0.21respectively, as shown in Table 7. 
Famotidine, the reference standard (group II) had total acidity 28.1±0.84, as 
shown in Table 13. Dose has been increased the totel acidity significantly 
reduced  which showing the table no:13 
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Effect  of AEDB  on Ulcer index using NSAID induced 
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Ulcer Index
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Table No :13 : Effect of AEDB on Total Acidity on NSAID induced Ulcer 
model 
S.No Treatment Dose 
Total Acidity 
(m Eq/L) 
 
1 
 
Control 
(water) 
 
- 
 
73.14±1.13 
 
2 
 
Famotidine 
 
3mg/kg 
 
28.1±0.84** 
 
3 
 
AEDB 
 
 
100mg/Kg 
 
    75.6±0.22* 
 
4 
AEDB 
 
 
200mg/Kg 
 
67.06±0.516* 
 
5 
AEDB 
 
400mg/Kg 
 
40.20±0.21** 
 
 
AEDB - Alcoholic Extract ofDesmostachyabipinnata 
**P<0.001, *P<0.05, compared with control 
Fig. No : 8 : Effect of AEDB on Total Acidity on NSAID induced Ulcer 
model 
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Effect of AEDB on Acid Volume on NSAID induced Ulcer model 
AEDB showed reduction in acid volume at all doses tested when 
compared with control as reflected by the acid volume values. The acid 
volume value of group I which served as control (water) was 5.30±0.21. The 
total acidity of group III (100mg/kg), group IV (200mg/kg) and group V 
(400mg/kg) was 5.10±0.11, 4.32±0.09, 4.04±0.04 respectively, as shown in 
Table 7. Famotidine, the reference standard (group II) had total acidity 
3.93±0.33, as shown in Table 14. 
Table No: 14: Effect of AEDB on Acid Volume on NSAID induced Ulcer 
model 
 
 
 
 
 
 
 
 
AEDB - Alcoholic Extract ofDesmostachyabipinnata 
**P<0.001, *P<0.05, compared with control 
Figure No : 9 : Effect of AEDB on Acid Volume on NSAID induced Ulcer 
model 
 
0
2
4
6
Control Standared AEDB
(100mg/kg)
AEDB
(200mg/kg)
AEDB
(400mg/kg)
 Effect of AEDB on Acid Volume in ASPIRIN 
induced ulcer model 
Acid Volume
S.No Treatment Dose 
Acid 
Volume 
(ml) 
 
1 
 
Control 
(water) 
 
- 
 
5.30±0.21 
 
2 
 
Famotidine 
 
3mg/kg 
 
3.93±0.33** 
 
3 
AEDB 
 
 
100mg/Kg 
 
5.10±0.11* 
 
4 
AEDB 
 
 
200mg/Kg 
 
4.32±0.09* 
 
5 
 
AEDB 
 
400mg/Kg 
 
4.04±0.04** 
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Effect of AEDB on pH in NSAID induced Ulcer model  
pH of gastric secretion of group I animals which served as control(water) 
was 2.15±0.10 and in group III (100mg/kg), group IV (200mg/kg), group V 
(400mg/kg) was 3.49±3.07, 3.22±4.77, 4.02±3.33 observed respectively. 
Group II standard (Famotidine) treated had pH 4.88±0.16, as shown in 
Table 15. 
Table No : 15 : Effect of AEDB on pH in NSAID induced Ulcer model 
 
 
 
 
 
 
 
 
 
 
 
AEDB - Alcoholic Extract ofDesmostachyabipinnata 
**P<0.001, *P<0.05, compared with control 
Fig. No : 10 : Effect of AEDB on p H on NSAID induced Ulcer model 
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Control Standared AEDB
(100mg/kg)
AEDB
(200mg/kg)
AEDB
(400mg/kg)
Effect of AEDB on pH in Aspirin induced ulcer model 
PH
S.No Treatment Dose PH 
 
1 
 
Control 
(water) 
 
- 
 
2.15±0.10 
 
2 
 
Famotidine 
 
3mg/kg 
 
4.88±0.16** 
 
 
3 
AEDB 
 
 
100mg/Kg 
 
3.49±3.05 
 
4 
AEDB 
 
 
200mg/Kg 
 
3.82±4.77** 
 
5 
AEDB 
 
 
400mg/Kg 
 
4.02±3.33** 
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Effect of AEDB on Glutathione in NSAID induced Ulcer model 
Since glutathione is intimately associated with the prevention of gastric 
erosions. It was thought worthwhile to measure glutathione level in control 
and treated rats. As shown in table 9, group I animals which served as control 
had glutathione level 0.93±0.012. In group III (100mg/kg), group IV 
(200mg/kg), group V (400mg/kg) the glutathione level was 0.88±0.012, 
1.22±0.094, 1.02±0.024 respectively, as shown in Table 16. The level of 
glutathione of Group II standard (Famotidine) treated was 1.14±0.19. 
Table No : 16 : Effect of AEDB on Glutathione in NSAID induced Ulcer 
model 
 
 
 
 
 
 
 
 
 
AEDB - Alcoholic Extract ofDesmostachyabipinnata 
**P<0.001, *P<0.05, compared with control 
 
 
 
 
 
S.No Treatment Dose 
Glutathione 
(mcg/gm) 
1 
Control 
(water) 
- 0.93±0.012 
2 Famotidine 3mg/kg 1.14±0.19* 
3 
AEDB 
 
100mg/kg 0.88±0.065 
4 
AEDB 
 
200mg/kg 1.22±0.094 
5 
AEDB 
 
400mg/kg 1.41±0.024* 
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Fig. No :11 : Effect of AEDB on Glutathione in NSAID induced Ulcer 
model 
 
 
 
 
 
Effect of AEDB on Total Protein in NSAID induced Ulcer 
AEDB was also studied for its effect on total protein content of the 
gastric juice. It showed rise in protein content in the control group whereas 
pre-treatment with AEDB at different dose levels was observed as declining 
the protein content. Simultaneously, there was a fall in the protein content in 
Famotidine treated group. The total protein content of the group I which 
served control was 0.842±0.02. Group III (100mg/kg), group IV (200mg/kg), 
group V (400mg/kg) was having the total protein content 0.740±0.09, 
0.672±0.05 and 0.650±0.02 respectively. Famotidine which was used as 
standard (Group II) had total protein content 0.700±0.03, as shown in Table 
17. Dose has been increased the ulcer index significantly reduced  which 
showing the table no:17. 
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Table No : 17 : Effect of AEDB on Total Protein in NSAID induced Ulcer 
 
 
 
 
 
 
 
 
AEDB - Alcoholic Extract ofDesmostachyabipinnata 
**P<0.001, *P<0.05, compared with control 
Fig. No : 12 :  Effect of AEDB on Total Protein in NSAID induced  
Ulcer Model 
 
 
 
 
                            
0
0,5
1
Control Standared AEDB
(100mg/kg)
AEDB
(200mg/kg)
AEDB
(400mg/kg)
Effect of AEDB on Total Protein in NSAID 
induced ulcer model 
Total Protein
S.NO Treatment Dose Totel ptotein 
gm/dl 
1 
Control 
(water) 
- 0.842±0.02 
2 Famotidine 3mg/kg 0.720±0.03* 
3 
AEDB 
 
100mg/kg 0.740±0.09 
4 
AEDB 
 
200mg/kg 0.672±0.05* 
5 
AEDB 
 
400mg/kg 0.650±0.02* 
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                                                      CHAPTER VIII 
              8. SUMMARY AND CONCLUSION 
The present study is evaluated the antioxidant potential and antiulcer 
effect of AEDB. The results analysed from the present study have indicate 
that AEDB possesses antioxidant and antiulcer effect on aspirin induced 
ulcers.  
The preliminary phytochemical screening of whole plant extracts indicate 
in presence of flavonoid, alkaloid, proteins,amino acids and terpenoids, fixed 
oil and glycosides 
       Pre-treatment with AEDB particularly at a dose of 400mg/kg in a single 
schedule and 400mg/Kg treatment significantly reduce the ulcer index value, 
total acidity concentration, total volume of acid release and total protein and 
increase value pH and glutathione content as compared with 100 
mg/kg,200mg/kg and control groups. 
The antioxidant screening shows that it showed reducing power to DPPH 
radicals. But the efficiency showed that far below from Vitamin C. The 
concentration of the AEDB  needed to scavenge 50% superoxide anion (IC50) 
equal to that of standard hence the  plant extract have the significant 
antioxidant activity  
The antiulcer effect is screened in ethanol extract of 
Desmostachyabipinnata on NSAID induced anti-ulcer study. The results get 
from these study have been shown that ethanol extract of 
Desmostachyabipinnata produce antiulcer effect.In aspirin induced model, 
there is reduction in ulcer index, total acidity, total volume of gastric contents, 
total protein concentration and higher concentration of glutathione content and 
pH of gastric secretion they compared with control group. Famotidine used as 
a standard comparison agents. Famotidine used as H2 receptor blocker, is 
significantly reduce about 90% of basal, food induced and hormonal mediated 
gastric acid, which again induced by histamine, gastrin, parasympathomimetic 
drugs and vagal stimulation. Famotidine mediate its suppression of gastric 
secretion by inhibiting the histamine mediated c-AMP dependent pathway 
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Famotidine encouraged certain type mucus analogues of gastric mucus for 
patients with duodenal ulcer. 
Total acidity responsible quantification acid is present in the gastric 
secretion. It has a important aggressive factor which induced the ulcer. 
Gastric release is maintained by vagal control and higher activity of vagus 
stimulation also contributes to ulcer formation. On ethanol administration, the 
mucosal mast cells mediate to secretion of vasoactive mediators containing 
histamine. Histamine is mediated to stimulate the synthesis of cyclic AMP 
through activation of the enzyme adenylcyclase which mediate the activation 
of gastric proton pump and secrete of hydrogen ions. The treatment of 
extracts showed reduce the total acidity of the gastric contents.  
Serum protein including albumin and globulin. In the peptic ulcer the total 
protein concentration of serum or gastric secretion are increased. This may be 
due to leakage of plasma protein in to the gastric secretion or serum with 
lower mucosal resistance/barrier of the gastric mucosal layer.After treatment 
with AEDB there was a significant reduction in protein concentration of gastric 
juice which enhancing leakage of plasma proteins.  
Acid volume is amount (in ml) of acid release in the gastric content release 
contain HCl, pepsinogen enzyme, mucus secretion, bicarbonates 
concentration, intrinsic factor and proteins. Amount of acid release is an 
important factor responsible for the production of ulcer mediated by exposure 
of the unprotected lumen of stomach by concentrated acids. AEDB treatment 
showed decrease in the acid volume of the gastric secretion. 
Increased pH shows a lower concentration of the hydrogen ion. The 
hydrogen ion is a major triggering factor responsible for the etiologic factor for 
ulcer and gastric damage. AEDBtreatment indicate higher concentration of pH 
of the gastric juices. This values directly shown the AEDB reduce possibility of 
ulcer and has a protective effect of surface of the gastric mucosa.     
In gastric ulcer tissues, Glutathione (g-glutamylcysteinylglycine, GSH) 
levels were found to be decreased112. aspirin-induced genesis of free radical 
concentration reduces the cysteine concentration which mediated for GSH 
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released.Values from this study responsible for depletion of gastric GSH is 
related with induction of gastric lesion in the rats. GSH is a tripeptide and 
having a superoxide radical scavenger and it protect thiol protein contents 
essential for release the integrity of tissue against oxidation reaction. In my 
present study, AEDB treatment showed increase in the glutathione content. 
 
All these data indicate that the AEDB could be regarded as a 
favourable antioxidant and anti ulcer effect. Mechanism of action and 
therapeutic need to establish in future research   
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